Department of Otolaryngology-Head & Neck Surgery, University of Missouri, Columbia, MO, USA.
Ann Otol Rhinol Laryngol. 2022 Aug;131(8):880-891. doi: 10.1177/00034894211047463. Epub 2021 Sep 23.
Orocutaneous fistula (OCF) after reconstruction for oral cavity resection can lead to prolonged hospitalization and adjuvant treatment delay. Few studies have examined factors leading to OCF after oral cavity resection. Primary objective: evaluate overall incidence and factors associated with OCF after oral cavity reconstruction.
Scopus 1960-database was searched for terms: "orocutaneous fistula," "oro cutaneous fistula," "oral cutaneous fistula," "orocervical fistula," "oral cavity salivary fistula."
English language studies with >5 patients undergoing reconstruction after oral cavity cancer resection were included. About 1057 records initially screened; 214 full texts assessed; 78 full-texts included. PRISMA guidelines were followed, and MINORS criteria used to assess risk of bias. Data were pooled using random-effects model. Primary outcome was OCF incidence. Meta-analysis to determine the effect of preoperative radiation on OCF conducted on 12 eligible studies. Pre-collection hypothesis was that prior radiation therapy is associated with increased OCF incidence. Post-collection analyses: free versus pedicled flaps; mandible-sparing versus segmental mandibulectomy.
Seventy-eight studies were included in meta-analysis of overall OCF incidence. Pooled effect size showed overall incidence of OCF to be 7.71% (95% CI, 6.28%-9.13%) among 5400 patients. Meta-analysis of preoperative radiation therapy on OCF showed a pooled odds ratio of 1.68 (95% CI, 0.93-3.06). OCF incidence was similar between patients undergoing free versus pedicled reconstruction, or segmental mandibulectomy versus mandible-sparing resection.
Orocutaneous fistula after oral cavity resection has significant incidence and clinical impact. Risk of OCF persists despite advances in reconstructive options; there is a trend toward higher risk after prior radiation.
口腔切除术后的口皮瘘(OCF)可导致住院时间延长和辅助治疗延迟。很少有研究探讨口腔切除术后发生 OCF 的相关因素。主要目的:评估口腔重建后 OCF 的总体发生率及相关因素。
在 Scopus 1960 年数据库中搜索了“口皮瘘”“口皮瘘”“口腔皮瘘”“口颈瘘”“口腔唾液瘘”等术语。
纳入了 >5 例接受口腔癌切除术后重建的患者的英语语言研究。最初筛选了约 1057 条记录,评估了 214 篇全文,纳入了 78 篇全文。遵循 PRISMA 指南,使用 MINORS 标准评估偏倚风险。使用随机效应模型对数据进行汇总。主要结局为 OCF 发生率。对 12 项符合条件的研究进行了术前放疗对 OCF 影响的荟萃分析。先验假设是术前放疗与 OCF 发生率增加有关。在收集后分析:游离皮瓣与带蒂皮瓣;保留下颌骨与节段性下颌骨切除术。
78 项研究纳入了对 OCF 总体发生率的荟萃分析。汇总效应大小显示,5400 例患者的 OCF 总发生率为 7.71%(95%CI,6.28%-9.13%)。术前放疗对 OCF 的荟萃分析显示,OCF 的合并优势比为 1.68(95%CI,0.93-3.06)。游离皮瓣与带蒂皮瓣重建、节段性下颌骨切除术与保留下颌骨切除术后,OCF 发生率相似。
口腔切除术后 OCF 的发生率和临床影响显著。尽管重建选择有所进步,但 OCF 的风险仍然存在;有先前放疗风险增加的趋势。